Japanese Drug Firm to Buy U.S. Company
<i> Reuters</i>
TOKYO — Japan’s Chugai Pharmaceutical Co. today said it will pay about $100 million for Gen-Probe, a leading U.S. drug maker researching methods of detecting viruses and cancer.
Chugai, a major Japanese drug company specializing in anti-cancer technology, said this would be a friendly takeover. Gen-Probe is developing the promising DNA probe method for detecting AIDS (acquired immune deficiency syndrome).
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
